Glaukos Total Liabilities 2014-2025 | GKOS
Glaukos total liabilities from 2014 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
- Glaukos total liabilities for the quarter ending March 31, 2025 were $0.202B, a 58.1% decline year-over-year.
- Glaukos total liabilities for 2024 were $0.208B, a 56.58% decline from 2023.
- Glaukos total liabilities for 2023 were $0.479B, a 1.33% increase from 2022.
- Glaukos total liabilities for 2022 were $0.472B, a 2.13% increase from 2021.
| Glaukos Annual Total Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $208 |
| 2023 | $479 |
| 2022 | $472 |
| 2021 | $463 |
| 2020 | $338 |
| 2019 | $145 |
| 2018 | $33 |
| 2017 | $28 |
| 2016 | $17 |
| 2015 | $21 |
| 2014 | $30 |
| 2013 | $24 |
| Glaukos Quarterly Total Liabilities (Millions of US $) |
|
|---|---|
| 2025-03-31 | $202 |
| 2024-12-31 | $208 |
| 2024-09-30 | $258 |
| 2024-06-30 | $255 |
| 2024-03-31 | $483 |
| 2023-12-31 | $479 |
| 2023-09-30 | $471 |
| 2023-06-30 | $468 |
| 2023-03-31 | $464 |
| 2022-12-31 | $472 |
| 2022-09-30 | $460 |
| 2022-06-30 | $469 |
| 2022-03-31 | $455 |
| 2021-12-31 | $463 |
| 2021-09-30 | $463 |
| 2021-06-30 | $459 |
| 2021-03-31 | $433 |
| 2020-12-31 | $338 |
| 2020-09-30 | $333 |
| 2020-06-30 | $333 |
| 2020-03-31 | $138 |
| 2019-12-31 | $145 |
| 2019-09-30 | $117 |
| 2019-06-30 | $114 |
| 2019-03-31 | $43 |
| 2018-12-31 | $33 |
| 2018-09-30 | $27 |
| 2018-06-30 | $23 |
| 2018-03-31 | $20 |
| 2017-12-31 | $28 |
| 2017-09-30 | $21 |
| 2017-06-30 | $20 |
| 2017-03-31 | $15 |
| 2016-12-31 | $17 |
| 2016-09-30 | $19 |
| 2016-06-30 | $19 |
| 2016-03-31 | $18 |
| 2015-12-31 | $21 |
| 2015-09-30 | $23 |
| 2015-06-30 | $33 |
| 2015-03-31 | $33 |
| 2014-12-31 | $30 |
| 2014-09-30 | $0 |
| 2014-06-30 | $0 |
| 2014-03-31 | $0 |
| 2013-12-31 | $24 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $5.932B | $0.383B |
| Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an alternative to the traditional glaucoma treatment and management paradigms. The company's iStent platform is the first MIGS device in the United States. Glaukos markets its products through direct sales force in the United States and other countries. It has distribution partners in Europe, the Asia Pacific, Latin America, and internationally. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $183.532B | 80.39 |
| Thermo Fisher Scientific (TMO) | United States | $164.157B | 19.86 |
| Edwards Lifesciences (EW) | United States | $45.784B | 30.02 |
| Alcon (ALC) | Switzerland | $43.149B | 29.16 |
| IDEXX Laboratories (IDXX) | United States | $42.895B | 49.29 |
| DexCom (DXCM) | United States | $32.690B | 50.53 |
| IQVIA Holdings (IQV) | United States | $28.164B | 15.77 |
| Mettler-Toledo (MTD) | United States | $25.437B | 30.25 |
| STERIS (STE) | Ireland | $22.432B | 24.70 |
| Waters (WAT) | United States | $21.001B | 29.63 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.363B | 0.00 |
| Hologic (HOLX) | United States | $14.645B | 15.91 |
| Sysmex ADR (SSMXY) | Japan | $10.626B | 30.14 |
| Penumbra (PEN) | United States | $9.214B | 72.32 |
| Masimo (MASI) | United States | $8.837B | 32.60 |
| Globus Medical (GMED) | United States | $7.733B | 18.43 |
| Teleflex (TFX) | United States | $5.144B | 8.49 |
| Integer Holdings (ITGR) | United States | $4.186B | 21.93 |
| TransMedics (TMDX) | United States | $3.804B | 82.69 |
| PROCEPT BioRobotics (PRCT) | United States | $3.134B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.417B | 14.39 |
| Veracyte (VCYT) | United States | $2.121B | 29.76 |
| Nihon Kohden (NHNKY) | Japan | $1.942B | 22.27 |
| Elekta AB (EKTAY) | Sweden | $1.903B | 17.10 |
| Alphatec Holdings (ATEC) | United States | $1.606B | 0.00 |
| Artivion (AORT) | United States | $1.343B | 125.84 |
| Pulse Biosciences (PLSE) | United States | $1.078B | 0.00 |
| OPKO Health (OPK) | United States | $1.071B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.038B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.978B | 5.20 |
| SiBone (SIBN) | United States | $0.733B | 0.00 |
| IRadimed (IRMD) | United States | $0.732B | 37.14 |
| Semler Scientific (SMLR) | United States | $0.623B | 13.51 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.552B | 8.58 |
| Beta Bionics (BBNX) | United States | $0.549B | 0.00 |
| AxoGen (AXGN) | United States | $0.542B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.532B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.471B | 11.05 |
| Pacific Biosciences Of California (PACB) | United States | $0.441B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.433B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.395B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.378B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.377B | 0.00 |
| RxSight (RXST) | United States | $0.325B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.319B | 0.00 |
| NeuroPace (NPCE) | United States | $0.312B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.260B | 0.00 |
| 908 Devices (MASS) | United States | $0.249B | 0.00 |
| Neuronetics (STIM) | United States | $0.236B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.232B | 14.03 |
| Inogen (INGN) | United States | $0.186B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.178B | 0.00 |
| CVRx (CVRX) | United States | $0.178B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.176B | 0.00 |
| LENSAR (LNSR) | United States | $0.154B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.147B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.143B | 0.00 |
| Accuray (ARAY) | United States | $0.140B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.123B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.121B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.117B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.115B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.095B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.073B | 0.00 |
| Spectral AI (MDAI) | United States | $0.072B | 0.00 |
| InspireMD (NSPR) | United States | $0.072B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.068B | 41.60 |
| Hyperfine (HYPR) | United States | $0.060B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.057B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.056B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.054B | 21.96 |
| Vicarious Surgical (RBOT) | United States | $0.048B | 0.00 |
| Precision Optics (POCI) | United States | $0.038B | 0.00 |
| Envoy Medical (COCH) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.032B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.026B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.022B | 0.00 | |
| NexGel (NXGL) | United States | $0.021B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.015B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.006B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.45 |